Effect of some natural mineral waters in nutrient uptake by Caco-2 cells

International Journal for Vitamin and Nutrition Research

Volumn 80, Issue 2, 2010, Pages 131-143

  Gonçalves, Pedro ^a   Araújo, João R ^a   Martel, Fátima ^a  

^a University of Porto   (Portugal)

Author keywords

Butyrate; Caco 2 cells; Glucose; Natural mineral waters; Uptake

Indexed keywords

3 METHYLGLUCOSE; BUTYRIC ACID; CALCIUM CHLORIDE; CALCIUM ION; CARBON 14; FLUORIDE ION; LITHIUM ION; MAGNESIUM CHLORIDE; MAGNESIUM ION; MAGNESIUM SULFATE; MELGACO; MINERAL WATER; PEDRAS SALGADAS; TRITIUM; UNCLASSIFIED DRUG; VIDAGO; BUTYRIC ACID DERIVATIVE;

ARTICLE; CELL STRAIN CACO 2; INTESTINE ABSORPTION; NUTRIENT UPTAKE; TIME; CACO 2 CELL LINE; CELL CULTURE; HUMAN; METABOLISM;

3-O-METHYLGLUCOSE; BUTYRATES; CACO-2 CELLS; CELLS, CULTURED; HUMANS; MINERAL WATERS; TIME FACTORS;

EID: 77956462585     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: 10.1024/0300-9831/a000013     Document Type: Article

References (83)

1. Petraccia, L., Liberati, G., Masciullo, S.G. et al. (2006) Water, mineral waters and health. Clin. Nutr. 25, 377-85.
2. Pignataro, G., Armuzzi, A., Valenti, A. et al. (1998) Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology 45, 727-32.
3. Cuomo, R., Grasso, R., Sarnelli, G. et al. (2002) Effects of carbonated water on functional dyspepsia and constipation. Eur. J. Gastroenterol. Hepatol. 14, 991-99.
4. Karagülle, O., Smorag, U., Candir, F. et al. (2007) Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOxurolithiasis. World J. Urol. 25, 315-23.
5. Katsuda, A.-I., Yasukawa, T., Nakagawa, K. et al. (2008) Deep-sea water improves cardiovascular hemodynamics in Kurosawa and Kusanagi- Hypercholesterolemic (KHC) rabbits. Biol. Pharm. Bull. 31, 38-44.
6. Miyamura, M., Yoshioka, S., Hamada, A. et al. (2004) Difference between deep seawater and surface seawater in the preventive effect of atherosclerosis. Biol. Pharm. Bull. 27, 1784-87.
7. Czernichow, S., Bertrais, S., Blacher, J. et al. (2005) SU.VI.MAX. Vascular Study. Metabolic syndrome in relation to structure and function of large arteries: a predominant effect of blood pressure. A report from the SU.VI.MAX. Vascular Study. Am. J. Hypertens. 18, 1154-60.
8. Itoh, K. and Kawasaki, T. (1998) Effect of low sodium, high potassium and high magnesium salt intake on blood pressure and lipid metabolism. J. Jpn. Soc. Nutr. Food Sci. 5, 1-7.
9. Katz, A., Rosenthal, T., Maoz, C. et al. (1999) Effect of a mineral salt diet on 24-h blood pressure monitoring in elderly hypertensive patients. J. Hum. Hypertens. 13, 777-80.
10. Vaskonen, T. (2003) Dietary minerals and modification of cardiovascular risk factors. J. Nutr. Biochem. 14, 492-506.
11. Rylander, R. and Arnaud, M.J. (2004) Mineral water intake reduces blood pressure among subjects with low urinary magnesium and calcium levels. BMC Public Health 4, 56.
12. Schoppen, S., Pérez-Granados A.M., Carbajal, A. et al. (2004) A Sodium-rich carbonated mineral water reduces cardiovascular risk in postmenopausal women. J. Nutr. 134, 1058-63.
13. Kiss, S.A., Forster, T. and Dongó, A. (2004) Absorption and effect of the magnesium content of a mineral water in the human body. J. Am. Coll. Nutr. 23, 758S-62S.
14. Gillette-Guyonnet, S., Andrieu, S., Nourhashemi, F. et al. (2005) Cognitive impairment and composition of drinking water in women: findings of the EPIDOS Study. Am. J. Clin. Nutr. 81, 897-902.
15. Bender, T., Bariska, J., Vághy, R. et al. (2007) Effect of balneotherapy on the antioxidant system-a controlled pilot study. Arch. Med. Res. 38, 86-9.
16. Costantino, M., Giuberdi, G., Caraglia, M. et al. (2009) Possible antioxidant role of SPA therapy with chlorine-sulphur-bicarbonate mineral water. Amino Acids 36, 161-5.
17. Roediger, W.E. (1980) Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 21, 793-8.
18. Roediger, W.E. (1982) Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 83, 424-9.
19. Scheppach, W., Bartram, P., Richter, A. et al. (1992) Effect of short-chain fatty acids on the human colonic mucosa in vitro. J. Parenter. Enteral Nutr. 16, 43-8.
20. Hague, A., Elder, D.J., Hicks, D.J. et al. (1995) Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int. J. Cancer 60, 400-6.
21. Heerdt, B.G., Houston, M.A. and Augenlicht, L.H. (1994) Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res. 54, 3288-293.
22. Medina, V., Edmonds, B., Young, G.P. et al. (1997) Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome dependent pathway. Cancer Res. 57, 3697-707.
23. Whitehead, R.H., Young, G.P. and Bhathal, P.S. (1986) Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM1215). Gut 27, 1457-63.
24. Gibson, P.R., Moeller, I., Kagelari, O. et al. (1992) Contrasting effects of butyrate on the expression of phenotypic markers of differentiation in neoplastic and non-neoplastic colonic epithelial cells in vitro. J. Gastroenterol. Hepatol. 7, 165-72.
25. Kripke, S.A., Fox, A.D., Berman, J.M. et al. (1989) Stimulation of intestinal mucosal growth with intracolonic infusion of short-chain fatty acids. J. Parent. Enter. Nutr. 13, 109-16.
26. Sakata, T. and von Engelhardt, W. (1983) Stimulatory effect of short-chain fatty acids on the epithelial cell proliferation in rat large intestine. Comp. Biochem. Physiol. 74 A, 459-62.
27. Binder, H.J. and Mehta, P. (1989) Short chain fatty acids stimulate Na and Cl absorption in vitro in the rat distal colon. Gastroenterology 96, 989-96.
28. Montrose, M.H. and Kere, J. (2001) Anion absorption in the intestine: anion transporters, short chain fatty acids, and role of the DRA gene product. Curr. Top. Membr. Transp. 50, 301-28.
29. Resta-Lenert, S., Trung, F., Barrett, K.E. et al. (2001) Inhibition of epithelial chloride secretion by butyrate: role of reduced adenylyl cyclase expression and activity. Am. J. Physiol. Cell Physiol. 281, C1837-C1849.
30. Hamer, H.M., Jonkers, D., Venema, K. et al. (2008) Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 27,104-19.
31. Wong, J.M.W., Souza, R., Kendall, C.W.C. et al. (2006) Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol. 40, 235-43.
32. Enerson, B.E. and Drewes, L.R. (2003) Molecular features, regulation, and function of monocarboxylate transporters: implications for drug delivery. J. Pharm. Sci. 92, 1531-44.
33. Halestrap, A.P. and Meredith, D. (2004) The SLC16 gene family - from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch.-Eur. J. Physiol. 447, 619-28.
34. Morris, M.E. and Felmlee, M.A. (2008) Overview of the proton-coupled MCT (SLC16 A) family of transporters: characterization, function and role in the transport of the drug of abuse gamma-hydroxybutyric acid. A.A.P.S. J. 10, 311-21.
35. Gupta, N., Martin, P.M., Prasad, P.D. et al. (2006) SLC5 A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter. Life Sci. 78, 2419-25.
36. Cuff, M., Dyer, J., Jones, M. et al. (2005) The human colonic monocarboxylate transporter isoform 1: its potential importance to colonic tissue homeostasis. Gastroenterology 128, 676-86.
37. Daly, K., Cuff, M.A., Fung, F. et al. (2005) The importance of colonic butyrate transport to the regulation of genes associated with colonic tissue homeostasis. Biochem. Soc. Trans. 33, 733-35.
38. Elbashir, S.M., Harborth, J., Lendeckel, W. et al. (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (London) 411, 494-98.
39. Lambert, D.W., Wood, I.S., Ellis, A. et al. (2002) Molecular changes in the expression of human colonic nutrient transporters during the transition from normality to malignancy. Br. J. Cancer 86, 1262-69.
40. Ganapathy, V., Gopal, E., Miyauchi, S. et al. (2005) Biological functions of SLC5 A8, a candidate tumour suppressor. Biochem. Soc. Trans. 33, 237-40.
41. Cuff, M.A. and Shirazi-Beechey, S.P. (2004) The importance of butyrate transport to the regulation of gene expression in the colonic epithelium. Biochem. Soc. Trans. 32, 1100-02.
42. Borthakur, A., Saksena, S., Gill, R.K. et al.: (2008) Regulation of monocarboxylate transporter 1 (MCT1) promoter by butyrate in human intestinal epithelial cells: involvement of NF-kappa B pathway. J. Cell Biochem. 103, 1452-63.
43. Cuff, M.A., Lambert, D.W., Shirazi-Beechey, S.P. (2002) Substrate-induced regulation of the human colonic monocarboxylate transporter, MCT1. J. Physiol. 539, 361-71.
44. Buyse, M., Sitaraman, S.V., Liu, X. et al. (2002) Luminal leptin enhances CD147/MCT-1-mediated uptake of butyrate in the human intestinal cell line Caco2-BBE. J. Biol. Chem. 277, 28182-90.
45. Alrefai, W.A., Tyagi, S., Gill, R. et al. (2004) Regulation of butyrate uptake in Caco-2 cells by phorbol 12-myristate 13-acetate. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G197-203.
46. Gonçalves, P., Araújo, J.R., Pinho, M.J. et al. (2009) Modulation of butyrate transport in Caco-2 cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 379, 325-36.
47. Borthakur, A., Gill, R.K., Hodges, K. et al. (2006) Enteropathogenic Escherichia coli inhibits butyrate uptake in Caco-2 cells by altering the apical membrane MCT1 level. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G30-G35.
48. Thibault, R., De Coppet, P., Daly, K. et al. (2007) Down-regulation of the monocarboxylate transporter 1 is involved in butyrate deficiency during intestinal inflammation. Gastroenterology 133, 1916-27.
49. Wright, E.M., Martín, M.G. and Turk, E. (2003) Intestinal absorption in health and disease-sugars. Best Pract. Res. Clin. Gastroenterol. 17, 943-56.
50. Affleck, J.A., Helliwell, P.A. and Kellett, G.L. (2003) Immunocytochemical detection of GLUT2 at the rat intestinal brush-border membrane. J. Histochem. Cytochem. 51, 1567-74.
51. Au, A., Gupta, A., Schembri, P. et al. (2002) Rapid insertion of GLUT2 into the rat jejunal brush-border membrane promoted by glucagon-like peptide 2. Biochem. J. 367, 247-54.
52. Drozdowski, L.A. and Thompson, A.B.R. (2006) Intestinal sugar transport. World J. Gastroenterol. 21, 1657-70.
53. Kellett, G.L. and Brot-Laroche, E. (2005) Apical GLUT2: a major pathway of intestinal sugar absorption. Diabetes 54, 3056-62.
54. Kellett, G.L. (2001) The facilitated component of intestinal glucose absorption. J. Physiol. 531, 585-95.
55. Delie, F. and Rubas, W. (1997) A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit. Rev. Ther. Drug Carr. Syst. 14, 221-86.
56. Sambuy, Y., De Angelis, I., Ranaldi, G. et al. (2005) The Caco-2 cell line as a model of intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol. Toxicol. 21, 1-26.
57. Bradford, M.M. (1976) A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-54.
58. Muzyka, A., Tarkany, O., Yelizanof, V. et al. (2005) Non-linear regression (curve fit). GraphPad Prism for Windows. San Diego, CA, USA.
59. th
60. Picoto, A. (1996) Mineral water and spas in Portugal. Clin. Dermatol. 14, 637-9.
61. Thomson, A.B. and Wild, G. (1997) Adaptation of intestinal nutrient transport in health and disease. Part I. Dig. Dis. Sci. 42, 453-69.
62. Hadjiagapiou, C., Schmidt, L., Dudeja, P.K. et al. (2000) Mechanism(s) of butyrate transport in Caco-2 cells: role of monocarboxylate transporter 1. Am. J. Physiol. Gastrointest. Liver Physiol. 279, G775-G780.
63. Lecona, E., Olmo, N., Turnay, J. et al. (2008) Kinetic analysis of butyrate transport in human colon adenocarcinoma cells reveals two different carrier-mediated mechanisms. Biochem. J. 409, 311-20.
64. Stein, J., Zores, M. and Schroeder, O. (2000) Short-chain fatty acid (SCFA) uptake into Caco-2 cells by a pH-dependent and carrier mediated transport mechanism. Eur. J. Nutr. 39, 121-25.
65. Ahmed, F.E. (2004) Effect of diet, life style, and other environmental/chemopreventive factors on colorectal cancer development, and assessment of the risks. J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev. 22, 91-147.
66. Bissonnette, P., Gagne, H., Coady, M.J. et al. (1996) Kinetic separation and characterization of three sugar transport modes in Caco-2 cells. Am. J. Physiol. 270, G833-43.
67. +/glucose co-transporter. Nature 330, 379-81.
68. Harris, D.S., Slot, J.W., Geuze, H.J. et al. (1992) Polarized distribution of glucose transporter isoforms in Caco-2 cells. Proc. Natl. Acad. Sci. USA 89, 7556-60.
69. Mahraoui, L., Rodolosse, A., Barbat, A. et al. (1994) Presence and differential expression of SGLT1, GLUT1, GLUT2, GLUT3 and GLUT5 hexose-transporter mRNAs in Caco-2 cell clones in relation to cell growth and glucose consumption. Biochem. J. 298, 629-33.
70. +-adenosine triphosphatase activity and gene expression in experimental diabetes mellitus. Dig. Dis. Sci. 44, 407-14.
71. Larsson, S.C., Bergkvist, L. and Wolk, A. (2005) Magnesium intake in relation to risk of colorectal cancer in women. JAMA 293, 86-9.
72. Larsson, S.C., Bergkvist, L. and Rutegård, J. (2006) Calcium and dairy food intakes are inversely associated with colorectal cancer risk in the Cohort of Swedish Men. Am. J. Clin. Nutr. 83, 67-73.
73. Martínez, M.E. and Willett, W.C. (1998) Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol. Biomarkers Prev. 7, 163-8.
74. Wolf, F.I., Maier, J.A., Nasulewicz, A. et al. (2007) Magnesium and neoplasia: from carcinogenesis to tumor growth and progression or treatment. Arch. Biochem. Biophys. 458, 24-32.
75. 2+) and 1,25-dihydroxyvitamin D(3). Cancer Res. 65, 493-8.
76. Yang, C.Y., Chiu, H.F., Chiu, J.F. et al. (1997) Calcium and magnesium in drinking water and risk of death from colon cancer. Jpn. J. Cancer Res. 88, 928-33.
77. Heaney, R.P. (2006) Calcium intake and disease prevention. Arq. Bras. Endocrinol. Metabol. 50, 685-93.
78. Hartwig, A. (2001) Role of magnesium in genomic stability. Mutat. Res. 475, 113-21.
79. Gueux, E., Azais-Braesco, V., Bussiere, L. et al. (1995) Effect of magnesium deficiency on triacylglycerol-rich lipoprotein and tissue susceptibility to peroxidation in relation to vitamin E content. Br. J. Nutr. 74, 849-56.
80. Hans, C.P., Chaudhary, D.P. and Bansal, D.D. (2003) Effect of magnesium supplementation on oxidative stress in alloxanic diabetic rats. Magnes. Res. 16, 13-19.
81. Shirazi-Beechey, S.P., Hirayama, B.A., Wang, Y. et al. (1991) Ontogenic development of lamb intestinal sodium-glucose co-transporter is regulated by diet. J. Physiol. 437, 699-708.
82. + on the intestinal absorption of sugars in vivo. Rev. Esp. Fisiol. 35, 367-73.
83. Shayiq, R.M. and Kidwai, A.M. (1986) Effect of fluoride on uptake of D-glucose by isolated epithelial cells of rat intestine. Environ. Res. 41, 388-99.